Abstract The common patterns of dissemination and recurrence of rectal cancer are known and well documented. However extravisceral involvement is a relatively uncommon entity. Therefore, these metastases are not well studied in sufficiently large numbers to formulate evidence based recommendations regarding their optimal treatment. This report describes a case of carcinoma of the rectum metastatic to the oral cavity causing symptoms severe enough to necessitate operative management.
Introduction
The advances in the diagnosis and treatment of rectal malignancies have led to increased overall survival, thereby increasing the likelihood of new patterns of recurrences and less documented areas of distant metastases. Metastatic involvement of oral cavity from rectal cancers is a rare occurrence. We report a rather rare case of a metachronous oral cavity metastasis in a 60 year old gentleman treated for rectal cancer.
Case Details
A 60 year old gentleman, a known case of carcinoma rectum since 2011 (T3N2M0) treated by surgery (APR), chemotherapy (5 -FU and XELOX combination) and radiation presented with history of swelling in the left mandible and severe trismus precluding food intake with foul smell and bleeding with excessive salivation since 2 months.
Clinical examination revealed a large proliferative growth involving the left buccal mucosa and gingivo-buccal sulcus and lower alveolus with foul smelling discharge from oral cavity. The growth bled on touch. There were no palpable lymph nodes in the neck.
Investigations revealed increased CEA (43.9), ALP (903) and LDH (1083) levels. A PET CT scan done showed an expansile osteolytic mass in the left ramus, angle and body of mandible with large extra soft tissue component infiltrating the submandibular and sublingual spaces measuring 7.7× 10.1×6 cm (SUV16.6). It also demonstrated metastases in the both adrenals (SUV 6.3) and right humerus (SUV13.5) Figs. 1, 2 and 3.
The severity of the patient's symptoms necessitated a palliative resection of the left hemimandible with a PMMC flap cover. Operative findings noted were growth arising from the mandible extending onto the buccal mucosa, alveolus and floor of mouth with few enlarged lymph nodes at levels I and II.
HPE revealed metastatic adenocarcinoma with signet ring cells and extra cellular mucin.
The tumor showed cortical destruction and was infiltrating the buccal mucosa.
The lymph nodes were positive for tumor and showed extra capsular extension.
On IHC, the tumor cells were positive for CK 20, CDX 2 and negative for CK 7.
An elevated CEA level and the IHC pattern characteristic of colorectal adenocarcinoma [1] put the diagnosis beyond doubt and the patient was diagnosed to have metachronous metastases in the mandible, adrenal glands and humerus.
The patient recovered well from the surgery and was advised palliative chemotherapy. But the patient refused chemotherapy. He presented 4 months later with spinal cord compression, cervical lymphadenopathy and multiple bony metastases and succumbed to the disease shortly afterwards.
Discussion
Despite advances in screening and treatment, approximately 50 % of patients with colorectal cancer eventually develop metastatic disease [2] . The most common sites of distant metastasis are to the liver and lung. Metachronous metastases most frequently develop after control of the primary, with the liver again being the most common site of involvement [3] .
Metastatic deposits to the oral cavity are rare, comprising approximately 1 % of all oral malignancies [4] . Of these, lung, kidney and prostate are the most common primaries in men with breast, genital organs and kidneys in women [5] . A high index of suspicion and careful work up including Immunohistochemical studies are needed to correctly diagnose these tumors as metastases from minor salivary gland adenocarcinomas can cause diagnostic dilemma. Colorectal adenocarcinoma metastases usually express CK20, but not CK7 [1] and usually have elevated CEA levels.
Presence of extrahepatic metastases, presence of more than 3 tumors and a disease free interval of fewer than 12 months have all been associated with a poor prognosis in patients with colorectal cancers [6] . The time from detection of metastases to death is a mean of 7.3 months [7] .
Long term disease free survival can be achieved in 25 to 40 % of selected patients who undergo resection of liver or lung only metastases [2] . For all other patients, treatment is largely palliative [2] .
A careful literature search using the search engine Google yielded 24 reported cases of oral cavity metastases from colorectal cancer. Majority of them was to the mandible (13 cases) with the remaining being gingiva (5 cases), and 1 case each involving hard palate, floor of mouth, tongue, tonsil and labial sulcus. One case was reported as oral cavity without specifying the subsite.
We picked ten well detailed case reports and compared them (Table 1) . Barring one case reported by Hiraoki Soda et al. [8] , all the other cases had multiple metastases at other sites as well and all of those cases had disease progression to death within a short duration. The case reported by Hiraoki Soda et al. [8] was unique in that the mandible was the only site with metastasis and the patient underwent a successful Fig. 3 Pleomorphic glands separated by fibrous septae curative surgery and was on follow up for three years at the time they reported the case. IHC was used in almost all the cases, underlining the importance of IHC in settling the diagnosis in such cases.
Conclusions
Metachronous metastasis from colorectal primary to the oral cavity is a rare entity. It is important, however, that the treating surgeon be alert to the possibility of such diagnostic surprises and have a high index of suspicion while dealing with such cases. However more often than not, they are associated with recurrences in multiple sites, precluding curative therapy. Nonetheless, surgical resection can also be done in selected cases with improvement in quality of life and occasionally, disease free survival. 
